RXO RXO Inc
- 29.985
- -0.165-0.55%
RXO Inc News
RXO (RXO): Buy, Sell, or Hold Post Q3 Earnings?
RXO Announces Participation at Upcoming Investor Conferences
'Busiest Thanksgiving Ever': How the TSA Plans to Handle Record Air Travel
BofA Securities Maintains RXO Inc(RXO.US) With Hold Rating, Cuts Target Price to $29
Goldman Sachs Reinstates Neutral on RXO, Announces $29 Price Target
Goldman Sachs Maintains RXO Inc(RXO.US) With Hold Rating, Raises Target Price to $29
Express News | RXO Inc : BofA Global Research Cuts Price Objective to $29 From $30
SIG Maintains RXO Inc(RXO.US) With Sell Rating, Cuts Target Price to $12
RXO Is Maintained at Negative by Susquehanna
RXO Price Target Maintained With a $33.00/Share by Citigroup
A Quick Look at Today's Ratings for RXO Inc(RXO.US), With a Forecast Between $12 to $33
RXO Inc. Price Target Lowered to $12 From $16 at Susquehanna
RXO Inc. Downgraded to Neutral From Buy at Citi
Sentiment Still Eluding RXO, Inc. (NYSE:RXO)
RXO Analyst Ratings
Wells Fargo Initiates RXO Inc(RXO.US) With Hold Rating, Announces Target Price $31
RXO Inc. Initiated With an Equal Weight at Wells Fargo
Barclays Maintains RXO Inc(RXO.US) With Buy Rating, Maintains Target Price $32
A Quick Look at Today's Ratings for RXO Inc(RXO.US), With a Forecast Between $25 to $31
BofA Securities Maintains RXO Inc(RXO.US) With Hold Rating, Maintains Target Price $30
Analysis
Price Target
No Data
No Data